Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
Int J Cancer
; 139(8): 1799-809, 2016 10 15.
Article
in En
| MEDLINE
| ID: mdl-27253354
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Immunotherapy, Adoptive
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Cytokine-Induced Killer Cells
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Int J Cancer
Year:
2016
Type:
Article
Affiliation country:
Germany